Gynuity envisions a world in which everyone has access to safe and effective reproductive and maternal health care—delivered where, when, and how needed.
Our mission is to develop and advocate for the use of scientific, clinical and programmatic evidence in reproductive and maternal health -- assuring that everyone benefits from the fruits of science and technology. We do this on a global scale through research, strategic partnerships, and communications for impact.
Our Approach
Gynuity listens to women, providers and policymakers, and works with them to create services that are safe, high quality, and person-centered. Through conversations and active collaborations, we use research to fill evidence gaps for new models of care, influence change, and advocate for improvements in policy and practice.
Research
Our research demonstrates that simple, safe, and effective reproductive and maternal health technologies transform lives and improve outcomes for women and girls.
Policy and Practice
Through speaking, convening partners, and publishing our research, we create the synergies that trigger change in policy and practice.
Communications for Impact
Strategic communications increase the impact of our research and programmatic findings.
News
Latest Resources
Effectiveness and Safety of Medication Abortion With vs Without Screening Ultrasonography or Pelvic Examination
Prognostic Accuracy of Clinical Markers of Postpartum Bleeding in Predicting Maternal Mortality or Severe Morbidity: A WHO Individual Participant Data Meta-Analysis
Evaluating Women's Experiences and Satisfaction With Labour Induction in India: A Comparison of the Participant Generated Experience and Satisfaction (PaGES) Index With Standard Methods
Proof-of-concept study establishes the potential of ulipristal acetate paired with misoprostol for early medication abortion.
Read peer-reviewed publication
A sample protocol for providing medication abortion to selected patients without routine facility-based tests.
Read commentary and protocol
“Period pills” treat delayed menses without a prior pregnancy confirmation.
Find out more
A systematic review and meta-analysis (2023) on misoprostol-only for medication abortion in the first 12 weeks of pregnancy.
Read key findings
Refreshed organizational strategy conveying our priority areas of engagement.
Read Refresh
WHO and colleagues assess prognostic accuracy of clinical markers in predicting women at risk of death or severe complications from excessive bleeding after childbirth.
Read meta-analysis
A seven-part podcast series charting how mifepristone came to the U.S. in the 1990s. Ep. 6 of ‘The Pill Plot’ includes clips from an interview with the president of Gynuity Health Projects.
Listen now or save for later